NO995033D0 - 6,7-disubstituted-4-aminopyrido [2,3-D] pyrimidine - Google Patents

6,7-disubstituted-4-aminopyrido [2,3-D] pyrimidine

Info

Publication number: NO995033D0
Authority: NO; Norway
Prior art keywords: aminopyrido; disubstituted; pyrimidine
Prior art date: 1997-04-16

Application number

NO995033A

Other languages

Norwegian (no)

Other versions

NO995033L (en

Inventor

Shripad S Bhagwat

Chih-Hung Lee

Richard J Perner

Yu-Gui Gu

Original Assignee

Abbott Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-04-16

Filing date

1999-10-15

Publication date

1999-10-15

1999-10-15 Application filed by Abbott Lab filed Critical Abbott Lab

1999-10-15 Publication of NO995033D0 publication Critical patent/NO995033D0/en

1999-12-15 Publication of NO995033L publication Critical patent/NO995033L/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Diabetes (AREA)
Rheumatology (AREA)
Emergency Medicine (AREA)
Vascular Medicine (AREA)
Hematology (AREA)
Obesity (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Heart & Thoracic Surgery (AREA)
Transplantation (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Psychiatry (AREA)
Cardiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)

NO995033A 1997-04-16 1999-10-15 6,7-disubstituted-4-aminopyrido [2,3-D] pyrimidine NO995033L (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US83439397A	1997-04-16	1997-04-16
PCT/US1998/004127 WO1998046603A1 (en)	1997-04-16	1998-04-16	6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds

Publications (2)

Publication Number	Publication Date
NO995033D0 true NO995033D0 (en)	1999-10-15
NO995033L NO995033L (en)	1999-12-15

Family

ID=25266829

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO995033A NO995033L (en)	1997-04-16	1999-10-15	6,7-disubstituted-4-aminopyrido [2,3-D] pyrimidine

Country Status (20)

Country	Link
EP (1)	EP0979230A1 (en)
JP (1)	JP2001520649A (en)
KR (1)	KR20010006453A (en)
CN (1)	CN1259948A (en)
AR (1)	AR012435A1 (en)
AU (1)	AU744528B2 (en)
BG (1)	BG103861A (en)
BR (1)	BR9809088A (en)
CA (1)	CA2287465A1 (en)
CO (1)	CO4940439A1 (en)
HU (1)	HUP0001402A3 (en)
IL (1)	IL131892A0 (en)
NO (1)	NO995033L (en)
NZ (1)	NZ337844A (en)
PL (1)	PL336262A1 (en)
SK (1)	SK142099A3 (en)
TR (1)	TR199902456T2 (en)
TW (1)	TW458977B (en)
WO (1)	WO1998046603A1 (en)
ZA (1)	ZA982912B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2001057040A1 (en) *	2000-02-03	2001-08-09	Abbott Laboratories	6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
CN100376571C (en) *	2001-02-12	2008-03-26	霍夫曼-拉罗奇有限公司	6-substituted pyridopyrimidines
CN101356179A (en)	2004-11-12	2009-01-28	塔夫茨大学信托人	lipase inhibitor
US20100063032A1 (en) *	2007-03-28	2010-03-11	Debenham John S	Substituted pyrido[2,3-d]pyrimidine derivatives as cannabinoid-1 receptor modulators
KR20150072412A (en) *	2012-10-05	2015-06-29	리겔 파마슈티칼스, 인크.	Gdf-8 inhibitors
US10016432B2 (en)	2016-05-27	2018-07-10	Legacy Emanuel Hospital & Health Center	Methanocarba derivatives of pseudoribose that inhibit adenosine kinase

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB774094A (en) *	1953-01-02	1957-05-08	Wellcome Found	Improvements in or relating to pyrimidine compounds
IL112249A (en) *	1994-01-25	2001-11-25	Warner Lambert Co	Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds

1998
- 1998-03-27 TW TW087104674A patent/TW458977B/en not_active IP Right Cessation
- 1998-04-06 ZA ZA982912A patent/ZA982912B/en unknown
- 1998-04-14 CO CO98020309A patent/CO4940439A1/en unknown
- 1998-04-15 AR ARP980101732A patent/AR012435A1/en unknown
- 1998-04-16 CN CN98806072A patent/CN1259948A/en active Pending
- 1998-04-16 KR KR1019997009543A patent/KR20010006453A/en not_active Withdrawn
- 1998-04-16 HU HU0001402A patent/HUP0001402A3/en unknown
- 1998-04-16 SK SK1420-99A patent/SK142099A3/en unknown
- 1998-04-16 AU AU70981/98A patent/AU744528B2/en not_active Ceased
- 1998-04-16 EP EP98917950A patent/EP0979230A1/en not_active Withdrawn
- 1998-04-16 NZ NZ337844A patent/NZ337844A/en unknown
- 1998-04-16 TR TR1999/02456T patent/TR199902456T2/en unknown
- 1998-04-16 CA CA002287465A patent/CA2287465A1/en not_active Abandoned
- 1998-04-16 JP JP54387898A patent/JP2001520649A/en active Pending
- 1998-04-16 BR BR9809088-7A patent/BR9809088A/en not_active IP Right Cessation
- 1998-04-16 PL PL98336262A patent/PL336262A1/en unknown
- 1998-04-16 WO PCT/US1998/004127 patent/WO1998046603A1/en not_active Ceased
- 1998-04-16 IL IL13189298A patent/IL131892A0/en unknown
1999
- 1999-10-15 NO NO995033A patent/NO995033L/en not_active Application Discontinuation
- 1999-11-05 BG BG103861A patent/BG103861A/en unknown

Also Published As

Publication number	Publication date
TW458977B (en)	2001-10-11
CO4940439A1 (en)	2000-07-24
WO1998046603A1 (en)	1998-10-22
AR012435A1 (en)	2000-10-18
CN1259948A (en)	2000-07-12
HUP0001402A3 (en)	2001-01-29
TR199902456T2 (en)	2000-07-21
NO995033L (en)	1999-12-15
CA2287465A1 (en)	1998-10-22
AU744528B2 (en)	2002-02-28
SK142099A3 (en)	2000-05-16
JP2001520649A (en)	2001-10-30
IL131892A0 (en)	2001-03-19
ZA982912B (en)	1998-10-09
BG103861A (en)	2000-06-30
HUP0001402A2 (en)	2000-10-28
BR9809088A (en)	2000-08-01
NZ337844A (en)	2001-11-30
KR20010006453A (en)	2001-01-26
EP0979230A1 (en)	2000-02-16
PL336262A1 (en)	2000-06-19
AU7098198A (en)	1998-11-11

Publication	Publication Date	Title
ID26698A (en)	2001-02-01	PIROLO COMPOUNDS [2,3-d] PYRIMIDINE
DE69804273D1 (en)	2002-04-25	5h-thiazolo [3,2-a] pyrimidine derivatives
NO20021694D0 (en)	2002-04-10	Pyrazolo [4,3-d] pyrimidine
IS5722A (en)	2000-11-21	Pyrolo [2,3-dl] pyrimidine compounds
NO20022738D0 (en)	2002-06-07	Pyrrolo (2,3-d) pyrimidine
DE50001191D1 (en)	2003-03-06	PYRAZOLO [4, 3-D] PYRIMIDINE
ZA983177B (en)	1999-01-22	5,7-Disubstituted-4-aminopyrdo [2,3] pyrimidine compounds
NO995033D0 (en)	1999-10-15	6,7-disubstituted-4-aminopyrido [2,3-D] pyrimidine
NO995035D0 (en)	1999-10-15	5,6,7-trisubstituted-4-aminopyrido [2,3-D] pyrimidine
EP0904271A4 (en)	2002-01-23	5,6,7,8-tetrahydropyrido [2,3-d] PYRIMIDINE
DE69815072D1 (en)	2003-07-03	SUBSTITUTED 2,4-DIAMINOPYRIMIDINE

Legal Events

Date	Code	Title	Description
2003-01-06	FC2A	Withdrawal, rejection or dismissal of laid open patent application